IH
Ivan Hyep sold $808K of BCAX stock
Ivan Hyep, Chief Financial Officer of Bicara Therapeutics Inc. (BCAX), sold 28,000 shares of BCAX stock worth $808K, per an SEC Form 4 filed Jul 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 8, 2026, 2 days before it was made public.
BCAX has moved -68.5% since the trade date, from $28.99 to $9.12 (Nov 19, 2026 close).
- Traded
- Jul 8, 2026
- Disclosed
- Jul 10, 2026
- Filing delay
- 2 days
- Price since
- -68.5%
- Role
- Chief Financial Officer
- Source
- SEC Form 4